Skip to main content
. Author manuscript; available in PMC: 2018 Feb 13.
Published in final edited form as: Horm Mol Biol Clin Investig. 2015 Jan;21(1):89–106. doi: 10.1515/hmbci-2014-0049

Figure 2. H-scores from immunohistochemistry staining of NILCO components and targets in type I and type II EmCa from AAW.

Figure 2

H-scores were significantly higher in type II versus type I EmCa for Notch1 (p=0.0044), Notch4 (p=0.0081), JAG1 (p=0.0116), DLL4 (p=0.0042), survivin (p=0.0144), OB-R (p=0.0008) and IL-1R tI (p=0.0028).